Of Vaccine and Hesitancy

Food & Drug Law Journal, Vol. 77, 2022 symposium

61 Pages Posted: 26 Oct 2021 Last revised: 10 Jul 2022

Date Written: April 25, 2022


Vaccine hesitancy is as old as vaccine itself. Before COVID-19, the rate of vaccine hesitancy was miniscule and primarily — almost exclusively — attributed to religious reasons. People assumed — wrongfully in hindsight — this time would be the same. The public began asking when a vaccine could be ready almost as soon as the pandemic began. But the better question we should have asked, as we now know, is how many people would actually receive the vaccine when it becomes available? Every dimension of the COVID-19 pandemic has been politicized, from lockdown measures, masking, to the very existence of the virus. As with these issues, people were fractured over whether to be vaccinated, when, and with which vaccine. For instance, more than a third of Americans reported as of March 2021 that they remain hesitant about receiving the COVID-19 vaccine. Such an alarming rate of vaccine hesitancy prompts the research for this Article, investigating what makes hesitancy to the COVID-19 vaccine so widespread. Of particular interest is why racial disparities in COVID-19 vaccination rates persist.

Note: Funding: I received no specific funding for this research.

Declaration of Interests: None.

Keywords: COVID-19, pandemic, coronavirus, vaccine, hesitancy, resistance, FDA, CDC, Food and Drug Administration, Centers for Disease Control and Prevention, cure, treatment, prevention

JEL Classification: K00, K10, K19, K20, K29, K30, K39, K40, K41, K49

Suggested Citation

Tran, Jasper, Of Vaccine and Hesitancy (April 25, 2022). Food & Drug Law Journal, Vol. 77, 2022 symposium, Available at SSRN: https://ssrn.com/abstract=3932592

Jasper Tran (Contact Author)

Harvard Business School ( email )

Soldiers Field
Boston, MA 02163
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
PlumX Metrics